D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
PUT
Green Dot
GDOT
$758M
| $790K | ﹤0.01% |
+41,600
| New | +$959K |
|
3602
CALL
Itaú Unibanco
ITUB
$91.6B
| $788K | ﹤0.01% |
172,669
| – | – |
|
3603
PUT
NRG Energy
NRG
$26.9B
| $788K | ﹤0.01% |
+20,600
| New | +$822K |
|
3604
ONE Gas
OGS
$5.06B
| $787K | ﹤0.01% |
11,175
-36,234
| -76% | -$2.92M |
|
3605
Lyell Immunopharma
LYEL
$318M
| $786K | ﹤0.01% |
5,362
-8,080
| -60% | -$1.09M |
|
|
CBAY
3606
DELISTED
Cymabay Therapeutics
CBAY
| $786K | ﹤0.01% |
224,613
-40,728
| -15% | -$146K |
|
3607
Karyopharm Therapeutics
KPTI
$161M
| $785K | ﹤0.01% |
9,587
+5,687
| +146% | +$425K |
|
3608
CALL
Orion
OEC
$400M
| $785K | ﹤0.01% |
58,800
+14,400
| +32% | +$234K |
|
|
SPNS
3609
DELISTED
Sapiens International
SPNS
| $785K | ﹤0.01% |
40,919
-43,334
| -51% | -$981K |
|
3610
Cable One
CABO
$249M
| $784K | ﹤0.01% |
919
| – | – |
|
|
SAGE
3611
PUT
DELISTED
Sage Therapeutics
SAGE
| $783K | ﹤0.01% |
20,000
| – | – |
|
3612
Nurix Therapeutics
NRIX
$2.51B
| $782K | ﹤0.01% |
+60,014
| New | +$950K |
|
3613
Energy Recovery
ERII
$433M
| $780K | ﹤0.01% |
35,900
+20,100
| +127% | +$453K |
|
3614
Northeast Bank
NBN
$1.08B
| $780K | ﹤0.01% |
21,272
-4,581
| -18% | -$180K |
|
3615
Sea Limited
SE
$65.8B
| $779K | ﹤0.01% |
13,900
-55,633
| -80% | -$3.87M |
|
3616
Revvity
RVTY
$12.4B
| $776K | ﹤0.01% |
6,450
+4,713
| +271% | +$665K |
|
3617
Digimarc Corp
DMRC
$145M
| $774K | ﹤0.01% |
57,126
-3,097
| -5% | -$50.1K |
|
3618
Timken Company
TKR
$9.72B
| $774K | ﹤0.01% |
13,116
-11,656
| -47% | -$724K |
|
3619
Children's Place
PLCE
$55.8M
| $773K | ﹤0.01% |
25,024
-55,349
| -69% | -$2.33M |
|
|
WRK
3620
PUT
DELISTED
WestRock Company
WRK
| $772K | ﹤0.01% |
+25,000
| New | +$988K |
|
3621
Ooma
OOMA
$608M
| $770K | ﹤0.01% |
62,600
-10,938
| -15% | -$136K |
|
|
EIGR
3622
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $770K | ﹤0.01% |
3,407
-5,153
| -60% | -$1.27M |
|
3623
Biomea Fusion
BMEA
$90.4M
| $764K | ﹤0.01% |
78,082
+57,167
| +273% | +$656K |
|
|
TEN
3624
CALL
Tsakos Energy Navigation Ltd
TEN
$1.18B
| $764K | ﹤0.01% |
+50,000
| New | +$698K |
|
3625
PUT
AZZ Inc
AZZ
$4.41B
| $763K | ﹤0.01% |
+20,900
| New | +$871K |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.